Q5151 – Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
HCPCS Level II code · Q codes: Temporary Codes
HCPCS codeQ5151
- Long description
- Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
- Short description
- Inj, eculizumab-aagh, 2 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- April 1, 2025
- Last change
- April 1, 2025 – No change
Frequently asked questions
What is HCPCS code Q5151?
Q5151 is a HCPCS Level II code for injection, eculizumab-aagh (epysqli), biosimilar, 2 mg.
Does Medicare cover Q5151?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby Q codes
- Q5143 – Injection, adalimumab-adbm, biosimilar, 1 mg
- Q5144 – Injection, adalimumab-aacf (idacio), biosimilar, 1 mg
- Q5145 – Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg
- Q5146 – Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg
- Q5147 – Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg
- Q5148 – Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
- Q5149 – Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg
- Q5150 – Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg
- Q5152 – Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg
- Q5153 – Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg
- Q5154 – Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg
- Q5155 – Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
- Q5156 – Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
- Q5157 – Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg
- Q5158 – Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg
- Q5159 – Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.